Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00180258 · ClinicalTrials.gov registry record · Phase 2
Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure
A Phase 2 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,200
- Enrollment target
NCT00180258 is a Phase 2 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 2,200 participants.
The verdict
NCT00180258, a Phase 2 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,200 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether combined mortality and hospitalization in heart failure patients receiving optimal pharmacologic therapy can be reduced by combining optimal pharmacologic therapy and 1) biventricular pacing therapy alone or 2) biventricular pacing with defibrillation.
Interventions
- DEVICE Cardiac Resynchronization Therapy with & without defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2000-01 |
| Est. Completion | 2002-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00180258
The ClinicalTrials.gov registry entry for NCT00180258 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Resynchronization Therapy with & without defibrillator is the first listed.
NCT00180258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00180258 about?
NCT00180258 is a clinical study titled "Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure". The purpose of this study is to determine whether combined mortality and hospitalization in heart failure patients receiving optimal pharmacologic therapy can be reduced by combining optimal pharmacologic therapy and 1) biventricular pacing therapy alone or 2) biventricular pacing with defibrillatio...
What is the current status of trial NCT00180258?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,200 participants. The study started on 2000-01. Estimated completion is 2002-12.
What interventions are being tested in trial NCT00180258?
The interventions under investigation include: Cardiac Resynchronization Therapy with & without defibrillator (DEVICE).
Who is sponsoring clinical trial NCT00180258?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.